Covalon Technologies Ltd V.COV

Alternate Symbol(s): CVALF

Healthcare Biotechnology

Covalon Technologies Ltd. is a patient-driven medical device company. Through a portfolio of patented technologies and solutions for advanced wound care, infection prevention, and medical device coatings, the Company offers gentler and more compassionate options for patients to heal with less infections, less pain, and better outcomes. Its solutions are designed for patients and made for care providers. It leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold under Covalon’s name and by developing and commercializing medical products for other medical companies under development and license contracts. It provides a range of specialized medical devices, medical dressings and advanced medical technology designed for infection prevention, complex wound closure and perioperative care. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis.

TSXV:COV - Post by User

Covalon Technologies Ltd

Bullboard Posts

Comment by zenvestingon Oct 12, 2017 2:57pm

130 Views

Post# 26805950

RE:RE:RE:RE:RE:RE:MediClear Pre-Op Will Be A Home Run

We could only speculate what a licensing deal would look like....big up front payment and low royalty rates, or no upfront payment, some development milestone payments, and a high royalty percentage. Also, could Mediclear be bundled with Surgiclear to offer a bundled solution for pre-op to post-op? Wh knows? All I know is that after we got to claw back IV Clear & Surgiclear from Molnlycke after their poor sales performance for the first two years, I have confidence this team knows how to structure a deal in our best interest.

Bullboard Posts

2024, a breakthrough year for silver